<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856963/" ref="ordinalpos=2818&amp;ncbi_uid=5611027&amp;link_uid=PMC3856963" image-link="/pmc/articles/PMC3856963/figure/f7-0981877/" class="imagepopup">Figure 7. From: Cytoplasmic localization of wild-type survivin is associated with constitutive activation of the PI3K/Akt <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> and represents a favorable prognostic factor in patients with acute myeloid leukemia. </a></div><br /><div class="p4l_captionBody">Outcomes of AML patients according to the PI3K/Akt/CytSurWT activation pathway. Overall survival was calculated with Kaplan-Meier curves for all 66 intensively treated patients and relapse-free survival was calculated for intensively treated patients achieving complete remission. (A) Kaplan-Meier curves for overall survival according to PI3K/Akt/CytSurWT activation pathway status. (B) Kaplan-Meier curves for relapse-free survival according to PI3K/Akt/CytSurWT activation pathway status.</div></div>